Research > ETFs > ETF / ETP Commentary > 

T. Rowe Price ETFs: TKNZ Tops Returns, TCAF Draws Most Cash

A crypto fund and a technology fund posted the best September returns among T. Rowe Price ETFs. Investors, however, sent most of their new money to a different set of funds.Key Takeaways: Crypto, technology and growth strategies produced the three best September returns across T. Rowe Price’s ETF lineup. Investors favored a short-term bond fund and a SMID cap fund alongside the firm’s largest ETF. Bitcoin and ether together made up more than half of the new crypto fund’s holdings. Investors focused on a core stock fund, a short-term bond fund and a small- and midcap fund. Together, those three took in about $954 million, or roughly two-thirds of the lineup’s September inflows, based on ETF Database figures. On the performance side, the T. Rowe Price Active Crypto ETF (TKNZ) posted an 8.7% September return, ETF Database data shows. The fund launched July 15 and has about $25.3 million in assets. TKNZ typically holds five to 15 crypto assets and charges a 0.75% management fee, according to T. Rowe Price. Bitcoin and ether made up about 56% of the fund as of October 2. Close behind, the T. Rowe Price Technology ETF (TTEQ ) gained 8% and is up just over 38% this year, according to ETF Database. TTEQ focuses on companies that earn most of their revenue from technology, according to its factsheet. Chipmakers made up 61.2% of the portfolio as of June 30, and its expense ratio is 0.63%. See more: How Active Tech ETF TTEQ Smashed Its Benchmark The T. Rowe Price Growth Stock ETF (TGRW B-) also made the top three with a 2.7% return, according to ETF Database. The fund targets companies with strong earnings and cash flow growth and charges 0.52%, its factsheet shows.Investors Add $1.41 Billion to T. Rowe Price ETFsT. Rowe Price’s lineup includes 39 ETFs holding about $34.3 billion combined, according to ETF Database. All are actively managed, meaning portfolio managers pick the holdings rather than track an index. The T. Rowe Price Capital Appreciation Equity ETF (TCAF B+) led with $647.47 million, or nearly half of the lineup’s roughly $1.41 billion, in September inflows, ETF Database data shows. At $8.6 billion in assets, it is also the lineup’s largest fund. According to its factsheet, TCAF seeks strong return potential with lower risk than the S&P 500 Index, and it charges 0.31%. Next came the T. Rowe Price Ultra Short-Term Bond ETF (TBUX ), which gathered $171.61 million, according to ETF Database. The fund has a 4.37% dividend yield and pays out monthly. TBUX seeks a high level of income with small price swings, according to its factsheet. It holds shorter-term investment-grade bonds, meaning debt from borrowers with stronger credit ratings, and charges 0.17%. Rounding out the top three, the T. Rowe Price Small-Mid Cap ETF (TMSL B+) brought in $135.36 million, ETF Database data shows. TMSL looks for small- and midcap stocks with attractive valuations and improving earnings and charges 0.55%, according to its factsheet. For more news, information, and analysis, visit our Active ETF Content Hub.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.